Sphingosine Kinase Blockade Leads to Increased Natural Killer T Cell Responses to Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin’s lymphoma. Despite being responsive to combination chemotherapy, median survival remains around 5 years due to high rates of relapse. Sphingolipid metabolism regulates MCL survival and proliferation and we found that sphingosine-1-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Michael S., Sun, Wenji, Webb, Tonya J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226300/
https://www.ncbi.nlm.nih.gov/pubmed/32326225
http://dx.doi.org/10.3390/cells9041030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226300/
https://www.ncbi.nlm.nih.gov/pubmed/32326225
http://dx.doi.org/10.3390/cells9041030

Ejemplares similares